Brief Summary
Type:
Hematologic - Other
Study Type:
Treatment
Phase:
III
ClinicalTrials.gov Identifier:
NCT03584516
Study #:
STUDY00143620
Start Date:
Nov 03, 2019
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT03584516
View Complete Trial Details & Eligibility at ClinicalTrials.gov
